WallStSmart
GNLX

Genelux Corporation Common Stock

NASDAQ: GNLX · HEALTHCARE · BIOTECHNOLOGY

$2.67
+6.80% today

Updated 2026-04-30

Market cap
$114.70M
P/E ratio
P/S ratio
14,337.86x
EPS (TTM)
$-0.86
Dividend yield
52W range
$2 – $9
Volume
0.2M

Genelux Corporation Common Stock (GNLX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+25.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-11.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-34.6%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-06$0.00+100.0%$2.57$2.65+3.1%
2026-03-20$-0.24-9.9%$2.54$2.48-2.4%
2025-11-05$-0.21+4.5%$8.11$5.30-34.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.22$0.00+100.0%
2025-12-31$-0.22$-0.24-9.9%$8000.00-99.1%
2025-09-30$-0.22$-0.21+4.5%
2025-06-30$-0.22$-0.20+9.1%
2025-03-31$-0.22$-0.21+4.5%$452000.00+5550.0%
2024-12-31$-0.25$-0.25+0.0%$896000.00-38.8%
2024-09-30$-0.25$-0.19+24.0%
2024-06-30$-0.24$-0.22+8.3%
2024-03-31$-0.23$-0.29-26.1%$8000.00
2023-12-31$-0.19$-0.25-31.6%$1.46M
2023-09-30$-0.18$-0.20-11.1%

Frequently asked questions

Has Genelux Corporation Common Stock beaten earnings estimates?
Genelux Corporation Common Stock has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +25.9% over the last 4 quarters.
How does GNLX stock react to earnings?
GNLX stock has moved an average of -11.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.